Introduction
============

Gastric carcinoma is one of common malignant tumours from human digestive system, and a serious threat to human health. Gastric carcinoma currently ranks second in global tumour mortality \[[@b1]\]. Particularly in Asia and parts of South America, it is the most common epithelial malignancy and leading cause of cancer-related deaths \[[@b1], [@b2]\]. The aetiology of gastric carcinoma is very complex, including mutations of oncogenes and tumour suppressor genes and abnormalities in growth factors and their receptors \[[@b3]--[@b6]\]. However, it has not been effectively treated so far because of its biological characteristics. Most patients are either diagnosed at advanced stages, or developed a relapse after surgery with curative intent \[[@b1], [@b2]\]. So a clear understanding of the mechanisms of the development and progression of gastric carcinoma is crucial for developing new effective therapeutic drugs.

Compound K (20-O-β-D-glucopyranosyl-20(S)-protopanaxadiol, CK; [Fig. 1A](#fig01){ref-type="fig"}), also known as IH-901 or M1, is an intestinal bacterial metabolite of panaxoside Rb1, Rb2 and Rc \[[@b7]\]. It has a wide range of pharmacological effects. Some CK-related studies have been performed in various medical fields, such as neuropathy \[[@b8]\], dermatonosis \[[@b9]\], endocrinopathy \[[@b10]\] and digestive disease \[[@b11]\]. Studies confirmed that CK can inhibit the growth of a variety of tumour cells, for example, hepatoma \[[@b12], [@b13]\], lung carcinoma \[[@b14]\], colorectal carcinoma \[[@b15]\], glioma \[[@b16]\], etc. Further studies show that it can inhibit proliferation and induce apoptosis in tumour cells \[[@b12]--[@b20]\]. However, the mechanisms involved are not clearly understood.

![Effect of CK on the viabilities of human gastric carcinoma cells. (A) The chemical structure of Compound K (CK). (B) BGC823 cells were treated with different concentrations of CK (0, 2.5, 5.0, 7.5 and 10.0 μmol/l) for 24 hrs. (C) SGC7901 cells were treated with different concentrations of CK (0, 2.5, 5.0, 7.5 and 10.0 μmol/l) for 24 hrs. (D) BGC823 cells were treated with 5.0 μmol/l CK for different time periods (0, 12, 24, 36 and 48 hrs). (E) SGC7901 cells were treated with 5.0 μmol/l CK for different time periods (0, 12, 24, 36 and 48 hrs). The cell viabilities were determined by MTT assay. Data are reported as means ± S.D. of three separate experiments.](jcmm0016-0096-f1){#fig01}

Bid, a BCL2 homology (BH)3 domain-only agonist, is a BH3-only Bcl-2 family member with multiple functions \[[@b21], [@b22]\]. In most cases it functions in a truncated form. The cleaved form of Bid (tBid) is myristoylated, and translocated to the mitochondria where it activates oligomerization of Bak or Bax and induces cytochrome *c* release. Cytochrome *c* in turn activates the apoptotic cascade of caspases-9 and -3, leading to cell death \[[@b23], [@b24]\]. However, the cleavage of Bid may not be an absolute requirement for Bid to be pro-apoptotic. Full-length Bid can also translocate to mitochondria and get activated without cleavage \[[@b25]--[@b27]\]. Studies suggest that Bid also has functions in DNA damage repair \[[@b28], [@b29]\]. Bid has emerged as a central player linking death signals through surface death receptors to the core apoptotic mitochondrial pathway \[[@b30]\]. Bid can also induce the activation of different signalling pathways to promote or inhibit tumour development, and it may have different biological functions in different systems \[[@b31], [@b32]\]. Studies from our group indicate that Bid might be a potential target for tumour therapy \[[@b27], [@b30], [@b33]\].

In this study, we use human gastric carcinoma cell lines BGC823, SGC7901 and the model of human gastric carcinoma xenograft in nude mice to investigate the mechanisms of CK-induced apoptosis, especially CK\'s possible roles on Bid in human gastric carcinoma cells.

Materials and methods
=====================

Cell culture and cell viability assay
-------------------------------------

The human gastric carcinoma cell lines BGC823 (poorly differentiated) and SGC7901 (moderately differentiated) were obtained from Shanghai Institute of Cell Biology, Chinese Academy of Sciences, Shanghai, China, and were maintained in RPMI1640 (Roswell Park Memorial Institute) supplemented with 10% foetal bovine serum (FBS), 100 U/ml penicillin and 100 mg/ml streptomycin, at 37°C in a water-saturated atmosphere of 5% CO~2~. CK was purchased from Sigma Chemical Co. (St. Louis, MO, USA). The structure of CK is shown in [Figure 1A](#fig01){ref-type="fig"}. Cell viability was assessed by methyl thiazolyl tetrazolium (MTT) assay as previously described \[[@b27]\].

Cell morphological analysis
---------------------------

Cells were treated with 5.0 μM CK or 0.1% (v/v) dimethyl sulfoxide (DMSO) (control) for 24 hrs. Then they were incubated with 10 μg/ml Hoechst 33342 (Sigma) and observed under fluorescence microscope (Leica DMIRB; Leica, Wetzler, Germany).

Annexin V assays
----------------

Cells were cultured and treated with different concentrations of CK. At various time-points, cells were trypsinized and harvested. After centrifugation, the cells were washed, resuspended and stained for annexin V and propidium iodide (PI) as described in the manufacturer\'s instructions (Pharmingen, San Diego, CA, USA). The samples were analysed by Flow cytometry (FACScan; Becton Dickinson, Franklin Lakes, NJ, USA).

Cell cycle analysis
-------------------

Cell cycle was measured by propidium iodide labelling cellular nuclear DNA. The cells were incubated overnight to allow them to attach to the plate, and then treated with CK. Cell cycle was analysed by Becton Dickinson FACScan. The ratio of cells in the G0/G1, S and M phases of the cell cycle was determined by their DNA content.

Immunofluorescence double staining
----------------------------------

Immunofluorescence double staining was performed as previously described \[[@b27]\] with some modifications. Briefly, After CK treatment, cells were fixed with 4% paraformaldehyde, and permeabilized with 0.1% Triton X-100. Then, cells were incubated with mouse monoclonal antibody against Bid (1:200), and washed and subsequently incubated with a rabbit polyclonal antibody against Hsp60 (1:200) for another 1 hr at room temperature. The cells were then washed and subsequently incubated with both fluoresceine isothiocyanate (FITC)-conjugated goat antimouse and tetramethyl rhodamine isothiocyanate (TRITC)-conjugated goat anti-rabbit secondary antibodies at a dilution of 1:200 for 1 hr at room temperature. After rinsing, cells were mounted in ProLong Antifade solution onto glass slides and observed under fluorescence microscope (Leica DMIRB).

Cytosolic, nuclear and mitochondrial protein isolation
------------------------------------------------------

The cytosolic, nuclear and mitochondrial protein fractions were isolated according to our previously reported procedure \[[@b27]\]. Briefly, after treatment as indicated, cells were collected and resuspended in five volumes of ice-cold extract buffer A and were homogenized. The homogenates were centrifuged at 750 × *g* for 10 min. The supernatant was collected and centrifuged at 10,000 × *g* for 15 min. to obtain the mitochondria pellets. The supernatants were further centrifuged at 100,000 × *g* for 1 hr to collect the cytosolic fraction. For the isolation of the nuclear proteins, ice-cold extract buffer B was added to the pellet after 750 × *g* centrifugation. The pellet and buffer B were mixed by gently pipetting and kept on ice for 15 min. The mixture was then treated with 10% NP-40, and centrifuged at 10,000 × *g* for 30 sec. The supernatant was discarded and the pellet was resuspended and homogenized in extract buffer C, and then centrifuged at 10,000 × *g* for 20 min. The supernatant was collected as the nuclear fraction.

Western blot analysis
---------------------

Western blot was performed as previously described \[[@b34]\]. Protein Assay Kit for protein quantity analysis was purchased from Bio-Rad (Hercules, CA, USA). The enhanced chemiluminescence detection system was purchased from GE/Amersham (Piscataway, NJ, USA). The mouse monoclonal antibody against cytochrome *c* was obtained from ZYMED Laboratories, Inc. (South San Francisco, CA, USA). All other antibodies were provided by Santa Cruz (Santa Cruz, CA, USA).

Xenograft assays in nude mice
-----------------------------

*In vivo* animal experiments with female Balb/c nude mice were carried out in the Cancer Research Center, Medical College of Xiamen University. SGC7901 cells (2 × 10^6^/mouse) were implanted by subcutaneous injection into the right hind leg of the mouse. Then different doses of CK were administered to the mice by subcutaneous injection every other day for 4 weeks. Mice in untreated control groups were given normal saline alone. Shortly after treatment of CK, all mice were killed and examined for the growth of subcutaneous tumours and micrometastasis formation. Six nude mice were used in each set of experiment.

Immunohistochemical staining
----------------------------

The subcutaneous tumours and metastases were fixed in 10% formaldehyde and embedded in paraffin. Sections were then cut and immunohistochemical staining was performed as previously described \[[@b34]\]. For negative control, the primary antibody was substituted with normal mouse IgG.

Statistic analysis
------------------

Data are presented as the means ± S.D. for at least three separate determinations for each group. The differences between the groups were examined for statistical significance using the Student\'s t-test with SPSS software.

Results
=======

CK inhibits human gastric carcinoma cells survival
--------------------------------------------------

We determined the viabilities of BGC823 and SGC7901 cells treated with different concentrations of CK (0, 2.5, 5.0, 7.5 and 10.0 μmol/l) for 24 hrs and 5.0 μmol/l CK for different time periods (0, 12, 24, 36 and 48 hrs) using MTT assay. As shown in [Figure 1](#fig01){ref-type="fig"}, the cell viabilities were decreased in dose- and time-dependent manners, and BGC823 cells were more sensitive to CK treatment than SGC7901 cells.

CK induces apoptosis in human gastric cells
-------------------------------------------

Hoechst-33342 and annexin-V/PI staining assays were combined to investigate whether CK can induce human gastric carcinoma cells apoptosis. First, we observed the apoptotic morphology of BGC823 and SGC7901 cells treated with 5.0 μmol/l CK for 24 hrs, and found that the CK-treated cells had manifest brighter granular blue fluorescence and more apoptotic bodies compared with control group ([Fig. 2A](#fig02){ref-type="fig"}). Furthermore, we assessed the apoptotic rate of the cells treated with different concentrations of CK (0, 2.5, 5.0, 7.5 and 10.0 μmol/l) for 24 hrs and 5.0 μmol/l CK for different time periods (0, 12, 24, 36 and 48 hrs) using annexin V/PI staining assay. As shown in [Figure 2B and C](#fig02){ref-type="fig"}, CK-induced apoptosis in BGC823 and SGC7901 cells in a dose- and time-dependent manner and BGC823 cells were more sensitive to CK treatment than SGC7901 cells.

![CK induces apoptosis in human gastric carcinoma cells. (A) Effect of CK on the apoptotic morphology of human gastric carcinoma cells. Cells were stained with Hoechst-33342, and images were captured by fluorescence microscopy. Magnification, 100×. (B) Cells were treated with different concentrations of CK (0, 2.5, 5.0, 7.5 and 10.0 μmol/l) for 24 hrs. (C) Cells were treated with 5 μmol/l CK for different time periods (0, 12, 24, 36 and 48 hrs), and the apop-tosis was determined by annexin V/PI staining assay. Data are reported as means ± S.D. of three separate experiments. \* and \*\* indicate P \< 0.05 and P \< 0.01 compared with control group, respectively.](jcmm0016-0096-f2){#fig02}

CK induces cell cycle arrest in G2 phase in human gastric carcinoma cells
-------------------------------------------------------------------------

To identify the effect of CK on cell cycle of human gastric carcinoma cells, we determined the cell cycle distribution of BGC823 and SGC7901 cells treated with different concentrations of CK (0, 2.5 and 5.0 μmol/l) for 24 hrs using PI staining assay. As shown in [Figure 3A](#fig03){ref-type="fig"}, we found that CK-induced cell cycle arrest in G2 phase in BGC823 and SGC7901 cells. Further investigation was performed to locate the molecular mechanisms on how CK regulates cell cycle arrest in G2 phase in human gastric carcinoma cells. The Western blot analysis showed that CK up-related expression of p21 and down-related expression of cdc2 and cyclin B1. The statistic tests showed the significant differences between control and CK treatment groups ([Fig. 3B](#fig03){ref-type="fig"}).

![Effect of CK on the cell cycle distribution of human gastric carcinoma cells. (A) Cells were treated with different concentrations of CK (0, 2.5 and 5.0 μmol/l) for 24 hrs. The cell cycle distribution was determined by PI staining assay. Data are reported as means ± S.D. of three separate experiments. \* and \*\* indicate P \< 0.05 and P \< 0.01 compared with control group, respectively. (B) Cells were treated with different concentrations of CK (0, 2.5 and 5.0 μmol/l) for 24 hrs. The total protein was extracted and the expression of cell cycle-related proteins was analysed by Western blot assay. Data are reported as means ± S.D. of three separate experiments. \* and \*\* indicate P \< 0.05 and P \< 0.01 compared with control group, respectively.](jcmm0016-0096-f3){#fig03}

Expression of apoptosis-related proteins in human gastric carcinoma cells treated with CK
-----------------------------------------------------------------------------------------

To further clarify the apoptotic mechanisms of human gastric carcinoma cells induced by CK treatment, we analysed total proteins of BGC823 and SGC7901 cells treated with different concentrations of CK (0, 2.5, 5.0, 7.5 and 10.0 μmol/l) for 24 hrs using Western blot assay. We found that expression levels of Fas, Fas-L and Bcl-X~L~ were not changed significantly, but Bid and Bcl-2 were down-regulated, and poly ADP-ribose polymerase (PARP) was shown cleavage activation. Bcl-2 and Bid expression was analysed by statistic tests and significant differences between control and CK treatment groups were shown ([Fig. 4](#fig04){ref-type="fig"}). The results indicate that CK induces apoptosis in BGC823 and SGC7901 cells mainly through mitochondria-mediated internal pathway.

![Expression of apoptosis-related proteins in human gastric carcinoma cells treated with CK. (A) BGC823 cells were treated with different concentrations of CK (0, 2.5, 5.0, 7.5 and 10.0 μmol/l) for 24 hrs. (B) SGC7901 cells were treated with different concentrations of CK (0, 2.5, 5.0, 7.5 and 10.0 μmol/l) for 24 hrs. The total protein was extracted and the expression of apoptosis-related proteins was analysed by Western blot assay. Data are reported as means ± S.D. of three separate experiments, \* and \*\* indicate P \< 0.05 and P \< 0.01 compared with control group, respectively.](jcmm0016-0096-f4){#fig04}

CK induces Bid translocation in human gastric carcinoma cells
-------------------------------------------------------------

To detect the clear site-specific effect of Bid in BGC823 and SGC7901 induced by 5.0 μmol/l CK treatment for 24 hrs, we combined immunofluorescence and cell fractionation methods. 4,6-diamino-2-phenylindole (DAPI) and Hsp60 were used to stain nucleus and mitochondria, respectively. As shown in [Figure 5A](#fig05){ref-type="fig"}, Bid located in nucleus and cytoplasm in control groups. In CK-treated groups, we observed merged fluorescence between Bid and Hsp60, indicating that upon CK treatment, nuclear Bid translocated to mitochondria in BGC823 and SGC7901 cells. To further confirm this result, we separated nuclear, cytoplasmic and mitochondrial proteins of BGC823 and SGC7901 cells treated with 5.0 μmol/l CK for 24 hrs and analysed them using Western blot assay. Lamin B, β-tubulin and Hsp60 were chosen as specific markers to indicate nuclear, cytoplasmic and mitochondrial proteins, respectively. As shown in [Figure 5B](#fig05){ref-type="fig"}, we found that, upon CK treatment, expression level of nuclear Bid manifestly decreased. However, we did not observe obvious increase of Bid in mitochondria fraction, which might be due to further cleavage of Bid to t-Bid in mitochondria. We also measured the release of cytochrome *c*, an important indicator of apoptosis, and found that cytochrome *c* released to cytosol upon CK treatment.

![CK induces Bid translocation in human gastric carcinoma cells. (A) Effect of the site-specific morphology of Bid in human gastric carcinoma cells induced by CK treatment. Cells were treated with 5.0 μmol/l of CK for 24 hrs. The cellular locations of Bid were determined by immunofluorescence assay. DAPI and Hsp60 represent nucleus and mitochondria staining, respectively. Images were captured by fluorescence microscopy. Magnification, 400×. (B) Expression of cytosolic, nuclear and mitochondrial Bid and cytochrome *c* in human gastric carcinoma cells with CK treatment. Cells were treated with 5.0 μmol/l of CK for 24 hrs. The nuclear, cytoplasmic and mitochondrial proteins were segregated and analysed by Western blot assay.](jcmm0016-0096-f5){#fig05}

CK inhibits the proliferation of SGC7901 cells in the nude mice
---------------------------------------------------------------

We established the model of human gastric carcinoma xenograft in nude mice by injecting SGC7901 cells. Volume and weight of the transplanted tumours from the nude mice treated with different of doses of CK (0, 2.5, 5.0 and 10.0 mg/kg) were assessed. As shown in [Figure 6](#fig06){ref-type="fig"}, CK inhibited the proliferation of SGC7901 cells in nude mice. Meanwhile, the subcutaneous tumour tissues were examined by haematoxylin and eosin staining ([Fig. 6E](#fig06){ref-type="fig"}), and Bid, MMP-9 were analysed by immunohistochemical staining. Tumours from 10.0 mg/kg CK treatment group showed obviously decreased expression of Bid and MMP-9, together with the cellular debris and morphological changes associated with apoptosis. The results of Bid expression in immunohistochemical staining are in accordance with the results of the Western blot analysis in human gastric cancer cells treated with CK *in vitro* ([Fig. 4](#fig04){ref-type="fig"}).

![CK inhibits the proliferation of SGC7901 cells in nude mice. (A) and (B) Typical photographs of tumour samples from the nude mice treated with different doses of CK. SGC7901 cells were implanted by subcutaneous injection into the right hind leg of the mouse. The different doses of CK (0, 2.5, 5.0, 7.5 and 10.0 μmol/l) were administered to the mice by subcutaneous injection every other day. Mice in untreated control group were given normal saline alone. After 4 weeks, the mice were sacrificed and analysed. (C) Volume of tumour samples from nude mice treated with different doses of CK. (D) Weight of tumour samples from nude mice treated with different doses of CK. Data are reported as means ± S.D. of three separate experiments. \* and \*\* indicate P \< 0.05 and P \< 0.01 compared with control group, respectively. (E) The tumour samples of untreated and 10.0 mg/kg CK-treated were immunostained with anti-Bid and anti-MMP-9 antibody and analysed by haema-toxylin and eosin staining. (F) and (G) Liver samples of untreated and 10.0 mg/kg CK-treated were photographed. The samples were also analysed by immunohistochemical staining of Bid and MMP-9 and haematoxylin and eosin staining.](jcmm0016-0096-f6){#fig06}

On the other side, the reduction effect of CK on spontaneous gastric carcinoma metastasis cannot be clearly quantified in the liver samples of nude mice due to overcrowded matasis on the liver. However, in immunohistochemical staining, CK treatment group showed similarly depressed expression of Bid and MMP-9 ([Fig. 6G](#fig06){ref-type="fig"}).

Discussion
----------

Ginseng saponins have been widely reported to exert anticancer activity. CK is the main metabolite of protopanaxadiol type ginseng saponin by intestinal bacteria after oral administration of ginseng extract, and is speculated to be the major form of protopanaxadiol saponins absorbed from the intestine \[[@b35]--[@b37]\]. Previous studies showed that CK possesses various chemopreventive and chemotherapeutic activities including anti-tumour activity \[[@b38], [@b39]\]. Researchers also found that CK can effectively kill HepG2, a hepatocellular carcinoma cell line, whereas it has much less cytotoxic effect in normal human liver cell line \[[@b40]\], suggesting that CK might be a very good candidate drug for cancer targeting therapy. The effect of CK on the suppression of hepatocellular carcinoma cells survival has been studied in our previous report \[[@b13]\]. However, the roles of CK on gastric carcinoma are not clearly understood, and the molecular mechanisms of CK on inducing apoptosis in human gastric carcinoma cells have never been reported. Therefore, here, we focus on the cellular location and distribution of Bid, a key molecule in the process of CK-induced apoptosis in human gastric carcinoma cell lines BGC823 and SGC7901. In this report, we observed that CK significantly inhibits the viabilities of human gastric carcinoma cells in a dose- and time-dependent manner ([Fig. 1](#fig01){ref-type="fig"}). Using multiple *in vitro* and *in vivo* models, we reported that CK potently induced BGC823 and SGC7901 cells apoptosis ([Fig. 2](#fig02){ref-type="fig"}) and attenuated subcutaneous tumour growth ([Fig. 6](#fig06){ref-type="fig"}). Although the effect of CK on spontaneous gastric carcinoma metastasis has not been clearly quantified in the nude mice due to overcrowded metastasis sites on the liver, the immunohistochemical staining results showed that CK effectively reduced the expression of MMP-9, a metastasis related protein in the nude mice ([Fig. 6](#fig06){ref-type="fig"}), suggesting CK\'s inhibitory effect on tumour metastasis.

Cell cycle redistribution usually occurs in CK-induced apoptosis. Some studies reported that CK-induced tumour cell arrest in G0/G1 phase \[[@b12], [@b13], [@b41]\]. However, we found that CK-induced cell cycle arrest in G2 phase in BGC823 and SGC7901 cells, which indicates that CK might induce different types of cell cycle arrest in different tumour cell lines. There are different check points during cell cycle and cells can be arrested at different check points for repair or apoptosis. Our studies indicate that 5 μM CK treatment for 24 hrs can induce BGC823 and SGC7901 not only apoptosis but also cell cycle arrest in G2 phase. The reason might be that cells at different phases in cell cycle have different sensitivities to CK treatment. Some cells may arrest in G2 phase to perform repair, but some just enter apoptosis directly.

Entry of eukaryotic cells into mitosis is regulated by activation of cdc2 kinase. The physiological process is controlled at several steps including cyclin B1 binding. As one of cell cycle suppressor molecules, the important function of p21 is to induce cell cycle arrest by inhibiting CDKs. Our study indicates that CK induces cell cycle arrest in G2 phase in BGC823 and SGC7901 cells not only by inhibiting expression level of cyclin B1, but also by up-regulating p21 and down-regulating cdc2 indirectly. Cells at different cell cycle phases have different sensitivities to radiation in mammals. It is known that the cells at G2 and M phases are much more sensitive to radiation. Chae\'s group \[[@b14]\] found that pre-treatment of NCI-H460 human lung cancer cells with CK enhanced γ-ray radiation-induced cell death, indicating that CK possesses radiosensitizing effect. Our studies provided further evidence that CK might increase radiosensitivity of tumour cells by blockade of cells at G2 phase. However, cell cycle regulation is complicated and cell specific. Further study is essential to disclose the mechanism of CK on cell cycle arrest.

There are two classic apoptotic pathways in mammalian cells, namely internal pathway and external pathway, also known as mitochondria-mediated apoptotic pathway and death receptor-mediated apoptotic pathway, and they cross-talk. Some studies show that both pathways are involved in CK-induced tumour cell apoptosis \[[@b12]--[@b20]\]. To further clarify the apoptotic molecular mechanisms of human gastric carcinoma cells induced by CK, we analysed total proteins of BGC823 and SGC7901 cells treated with different concentrations of CK (0, 2.5, 5.0, 7.5 and 10.0 μmol/l) for 24 hrs using Western blot assay. We found that expression levels of Fas, Fas-L and Bcl-X~L~ were not changed significantly, but Bid and Bcl-2 were down-regulated by CK, and PARP showed cleavage activation. Cytochrome *c* release to cytoplasm induced by CK was also detected. The results show that CK induces apoptosis in BGC823 and SGC7901 cells mainly through mitochondria-mediated internal pathway ([Fig. 7](#fig07){ref-type="fig"}).

![The tentative mechanism of CK-induced apoptosis in human gastric carcinoma cells.](jcmm0016-0096-f7){#fig07}

Bid, a BH3 domain-only agonist, is a BH3-only Bcl-2 family member with multiple functions \[[@b21], [@b22]\]. Bid has emerged as a central player linking death signals through surface death receptors to the core apoptotic mitochondrial pathway \[[@b31]\]. The tBid is initially found to be myristoylated and translocated into mitochondria in response to death receptor-mediated apoptotic signalling. tBid is very unstable and has a half-life of less than 1.5 hrs \[[@b42]\]. However, the recent findings from our group and others have shown that the cleavage of Bid may not be an absolute requirement for Bid to be pro-apoptotic \[[@b25]--[@b27], [@b30], [@b43]\]. For example, the mutant Bid that lacks the caspase-8 cleavage site can still kill cells \[[@b26]\], and Bid has been shown to translocate to the mitochondria without cleavage \[[@b27]\]. Our results showed that Bid located in nucleus and cytoplasm and nuclear Bid translocated to mitochondria in BGC823 and SGC7901 cells by CK treatment ([Fig. 5](#fig05){ref-type="fig"}). Although we observed partial relocation of nuclear Bid to mitochondria in BGC823 and SGC7901 cells, mitochondrial Bid expression did not change significantly. In the mitochondria-mediated apoptosis pathway, Bid is mainly cleaved to tBid by activated Caspase-8, then tBid translates into mitochondria where it interact with some Bcl-2 family proteins and induces cytochrome *c* release into cytoplasm \[[@b23], [@b24]\]. tBid is a 15 KD protein and is easily degraded *via* ubiquitination pathway. So this might be a possible reason that we could not detect the change of mitochondrial Bid expression in BGC823 and SGC7901 cells with CK treatment.

In conclusion, the present studies demonstrated that CK, a novel ginseng saponin metabolite, could significantly inhibit the proliferation and induce apoptosis in human gastric carcinoma cells *via* Bid-mediated mitochondrial pathway. The elucidation of the mechanism of CK-induced tumour cell apoptosis suggests a possible therapeutic role of CK and its potential of combination with other chemotherapies targeting Bid to treat gastric carcinoma.
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